FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387665269> ?p ?o ?g. }

• W4387665269 abstract "The primary analysis of the GHSG HD16 trial indicated a significant loss of tumor control with PET-guided omission of radiotherapy (RT) in patients with early-stage favorable Hodgkin lymphoma (HL). This analysis reports long-term outcomes. Overall, 1150 patients aged 18-75 years with newly diagnosed early-stage favorable HL were randomized between standard combined-modality treatment (CMT) (2x ABVD followed by PET/CT [PET-2] and 20 Gy involved-field RT) and PET-2-guided treatment omitting RT in case of PET-2 negativity (Deauville score [DS] < 3). The study aimed at excluding inferiority of PET-2-guided treatment and assessing the prognostic impact of PET-2 in patients receiving CMT. At a median follow-up of 64 months, PET-2-negative patients had a 5-year progression-free survival (PFS) of 94.2% after CMT (n = 328) and 86.7% after ABVD alone (n = 300; HR = 2.05 [1.20-3.51]; p = 0.0072). 5-year OS was 98.3% and 98.8%, respectively (p = 0.14); 4/12 documented deaths were caused by second primary malignancies and only one by HL. Among patients assigned to CMT, 5-year PFS was better in PET-2-negative (n = 353; 94.0%) than in PET-2-positive patients (n = 340; 90.3%; p = 0.012). The difference was more pronounced when using DS4 as cut-off (DS 1-3: n = 571; 94.0% vs. DS ≥ 4: n = 122; 83.6%; p < 0.0001). Taken together, CMT should be considered standard treatment for early-stage favorable HL irrespective of the PET-2-result." @default.
• W4387665269 created "2023-10-17" @default.
• W4387665269 creator A5002071285 @default.
• W4387665269 creator A5003056562 @default.
• W4387665269 creator A5003363227 @default.
• W4387665269 creator A5019862530 @default.
• W4387665269 creator A5020097248 @default.
• W4387665269 creator A5023523782 @default.
• W4387665269 creator A5028397596 @default.
• W4387665269 creator A5028510513 @default.
• W4387665269 creator A5030433016 @default.
• W4387665269 creator A5037804056 @default.
• W4387665269 creator A5039994927 @default.
• W4387665269 creator A5040054777 @default.
• W4387665269 creator A5043426460 @default.
• W4387665269 creator A5046794427 @default.
• W4387665269 creator A5053252307 @default.
• W4387665269 creator A5055422099 @default.
• W4387665269 creator A5055488306 @default.
• W4387665269 creator A5057387418 @default.
• W4387665269 creator A5061291419 @default.
• W4387665269 creator A5061498879 @default.
• W4387665269 creator A5064132655 @default.
• W4387665269 creator A5065655150 @default.
• W4387665269 creator A5067716137 @default.
• W4387665269 creator A5068013617 @default.
• W4387665269 creator A5071581236 @default.
• W4387665269 creator A5076460303 @default.
• W4387665269 creator A5081442256 @default.
• W4387665269 creator A5085255418 @default.
• W4387665269 creator A5091739351 @default.
• W4387665269 date "2023-10-16" @default.
• W4387665269 modified "2023-10-18" @default.
• W4387665269 title "Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma" @default.
• W4387665269 cites W2011739229 @default.
• W4387665269 cites W2039888190 @default.
• W4387665269 cites W2051650384 @default.
• W4387665269 cites W2063394181 @default.
• W4387665269 cites W2101472190 @default.
• W4387665269 cites W2119843363 @default.
• W4387665269 cites W2123547378 @default.
• W4387665269 cites W2140801657 @default.
• W4387665269 cites W2146029220 @default.
• W4387665269 cites W2154059556 @default.
• W4387665269 cites W2160483964 @default.
• W4387665269 cites W2162848902 @default.
• W4387665269 cites W2166167499 @default.
• W4387665269 cites W2167555906 @default.
• W4387665269 cites W2591979535 @default.
• W4387665269 cites W2596050027 @default.
• W4387665269 cites W2607430423 @default.
• W4387665269 cites W2791031146 @default.
• W4387665269 cites W2972952899 @default.
• W4387665269 cites W3173831844 @default.
• W4387665269 cites W3191419669 @default.
• W4387665269 cites W4283072465 @default.
• W4387665269 cites W4294991500 @default.
• W4387665269 cites W4313334750 @default.
• W4387665269 cites W4378803141 @default.
• W4387665269 doi "https://doi.org/10.1038/s41375-023-02064-y" @default.
• W4387665269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37845285" @default.
• W4387665269 hasPublicationYear "2023" @default.
• W4387665269 type Work @default.
• W4387665269 citedByCount "0" @default.
• W4387665269 crossrefType "journal-article" @default.
• W4387665269 hasAuthorship W4387665269A5002071285 @default.
• W4387665269 hasAuthorship W4387665269A5003056562 @default.
• W4387665269 hasAuthorship W4387665269A5003363227 @default.
• W4387665269 hasAuthorship W4387665269A5019862530 @default.
• W4387665269 hasAuthorship W4387665269A5020097248 @default.
• W4387665269 hasAuthorship W4387665269A5023523782 @default.
• W4387665269 hasAuthorship W4387665269A5028397596 @default.
• W4387665269 hasAuthorship W4387665269A5028510513 @default.
• W4387665269 hasAuthorship W4387665269A5030433016 @default.
• W4387665269 hasAuthorship W4387665269A5037804056 @default.
• W4387665269 hasAuthorship W4387665269A5039994927 @default.
• W4387665269 hasAuthorship W4387665269A5040054777 @default.
• W4387665269 hasAuthorship W4387665269A5043426460 @default.
• W4387665269 hasAuthorship W4387665269A5046794427 @default.
• W4387665269 hasAuthorship W4387665269A5053252307 @default.
• W4387665269 hasAuthorship W4387665269A5055422099 @default.
• W4387665269 hasAuthorship W4387665269A5055488306 @default.
• W4387665269 hasAuthorship W4387665269A5057387418 @default.
• W4387665269 hasAuthorship W4387665269A5061291419 @default.
• W4387665269 hasAuthorship W4387665269A5061498879 @default.
• W4387665269 hasAuthorship W4387665269A5064132655 @default.
• W4387665269 hasAuthorship W4387665269A5065655150 @default.
• W4387665269 hasAuthorship W4387665269A5067716137 @default.
• W4387665269 hasAuthorship W4387665269A5068013617 @default.
• W4387665269 hasAuthorship W4387665269A5071581236 @default.
• W4387665269 hasAuthorship W4387665269A5076460303 @default.
• W4387665269 hasAuthorship W4387665269A5081442256 @default.
• W4387665269 hasAuthorship W4387665269A5085255418 @default.
• W4387665269 hasAuthorship W4387665269A5091739351 @default.
• W4387665269 hasBestOaLocation W43876652691 @default.
• W4387665269 hasConcept C126322002 @default.
• W4387665269 hasConcept C143998085 @default.
• W4387665269 hasConcept C146357865 @default.
• W4387665269 hasConcept C151730666 @default.
• W4387665269 hasConcept C2776305933 @default.

• next